Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

The tech-heavy Nasdaq Composite rallied more than 9% this month. Information technology stocks are the top-performing sector ...

SelectQuote Inc. faced renewed investor pressure on Monday, May 12, 2025, as its shares tumbled another 12% following the release of quarterly results that fell short of earnings and revenue ...

Highmark Health recorded $13 million in net income during the first quarter, down from a $194 million a year before.

UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high.

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

Major indices were little changed early on Wednesday as market participants awaited the release of minutes from the Federal ...

Humana recently reported robust first-quarter earnings with significant increases ... contributed to its share price decline of 10.22% over the last week. While the broader market indices like ...

Humana recently reported robust first-quarter earnings with significant increases in revenue ... contributed to its share price decline of 10.22% over the last week. While the broader market indices ...

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.